On July 14, 2025, Rafael Holdings, Inc. appointed N. Scott Fine as an ex-officio director and he will resign as CEO of Cyclo Therapeutics, receiving a severance of $852,168 and continued equity vesting. Additionally, the company updated its bylaws to include non-voting directors and the vice chairman role.